Download full report with analyst certification and important disclosures
May 5 2026, 07:05 IST/BST
Uniphar
Significant upgrades to forecasts and price target
- Sectors : Pharma and healthcare
- Companies : Uniphar
DAVY VIEW
We upgrade our Uniphar EPS forecasts by 7-8% in 2026 and 2027, driven by strong EBITDA growth and lower-than-expected finance charges. This is our fourth upgrade since the start of last year. We also raise our price target to €6.70, which is based on the company achieving its €200m EBITDA target in 2028.
